FOCAL SEGMENTAL GLOMERULOSCLEROSIS MARKET ANALYSIS

Focal Segmental Glomerulosclerosis Market by Disease Type (Primary Focal Segmental Glomerulosclerosis, and Secondary Focal Segmental Glomerulosclerosis), by Drug (Sparsentan (Phase III)), by Distribution Channels (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Geography - Size, Share, Outlook, and Opportunity Analysis, 2022-2028

To Be Published : Jan 2025
Code : CMI2224
Formats :
Excel and PDF
Industry : Pharmaceutical

Market Challenges And Opportunities

Focal Segmental Glomerulosclerosis Market – Restraint

Lack of awareness among population regarding this disease and high cost of dialysis therapy may restrict growth of this market to some extent. For instance, according to an article published in University of Michigan 2017, awareness among patients with FSGS is considerably low when the patients are in primary stage of FSGS, which is hampering growth of the FSGS market.